Polydeoxyribonucleotide restores blood flow in an experimental model of ischemic skin flaps

详细信息    查看全文

• 作者：Francesca Polito ; PhD^a ; ^b ; Alessandra Bitto ; MD ; PhD^b ; Mariarosaria Galeano ; MD^c ; Natasha Irrera ; JrD^b ; Herbert Marini ; MD^a ; Margherita Calò ; PhD^d ; Francesco Squadrito ; MD^b ; ^{francesco.squadrito@unime.it} ; Domenica Altavilla ; PhD^b
• 刊名：Journal of Vascular Surgery
• 出版年：2012
• 出版时间：February 2012
• 年：2012
• 卷：55
• 期：2
• 页码：479-488
• 全文大小：1940 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferences

Background

Ischemia is a major factor contributing to failure of skin flap surgery, which is routinely used for coverage of wounds to prevent infection and to restore form and function. An emerging concept is that adenosine A_2A receptors can improve tissue oxygenation by stimulating angiogenesis, likely through vascular endothelial growth factor (VEGF). This study assessed the ability of polydeoxyribonucleotide (PDRN) to restore blood flow and improve wound healing, acting through the A_2A receptor, in a rat model of ischemic skin flaps.

Methods

The H-shaped double-flap model was used in male Sprague-Dawley rats. After surgical procedures, the animals were randomized to receive intraperitoneal PDRN (8 mg/kg) or vehicle (NaCl 0.9 % ). Rats were euthanized 3, 5, and 10 days after skin injury, after the evaluation of skin perfusion by laser Doppler. The wounds underwent histologic analysis and were measured for VEGF messenger RNA and protein expression, hypoxia inducible factor-1-¦Á (HIF-1¦Á), and inducible nitric oxide synthase (iNOS) protein expression, and nitrite content.

Results

Blood flow markedly increased in blood flow in ischemic flaps treated with PDRN, with a complete recovery starting from day 5 (ischemic flap + vehicle, 1.80 ¡À 0.25; ischemic flap + PDRN, 2.46 ¡À 0.25; P < .001). Administration of PDRN enhanced the expression of VEGF (ischemic flap + vehicle, 5.3 ¡À 0.6; ischemic flap + PDRN, 6.2 ¡À 0.5; P < .01) at day 5, and iNOS (ischemic flap + vehicle, 3.9 ¡À 0.6; ischemic flap + PDRN, 5.3 ¡À 1; P < .01), but reduced HIF-1¦Á expression (ischemic flap + vehicle, 7 ¡À 1.1; ischemic flap + PDRN, 4.8 ¡À 0.5; P < .05) at day 3. Histologically, the PDRN-treated group showed complete re-epithelialization and well-formed granulation tissue rich in fibroblasts.

Conclusions

These results suggest that PDRN restores blood flow and tissue architecture, probably by modulating HIF-1¦Á and VEGF expression, and may be an effective therapeutic approach in improving healing of ischemic skin flaps.